UBA5

Chr 3AR

ubiquitin like modifier activating enzyme 5

Also known as: DEE44, EIEE44, SCAR24, THIFP1, UBE1DC1

This gene encodes a member of the E1-like ubiquitin-activating enzyme family. This protein activates ubiquitin-fold modifier 1, a ubiquitin-like post-translational modifier protein, via the formation of a high-energy thioester bond. Alternative splicing results in multiple transcript variants. A pseudogene of this gene has been identified on chromosome 1. [provided by RefSeq, Feb 2016]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.722 OMIM phenotypes
Clinical SummaryUBA5
🧬
Gene-Disease Validity (ClinGen)
genetic developmental and epileptic encephalopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 116 VUS of 304 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.72LOEUF
pLI 0.000
Z-score 2.58
OE 0.43 (0.260.72)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.29Z-score
OE missense 0.75 (0.660.85)
158 obs / 210.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.43 (0.260.72)
00.351.4
Missense OE?0.75 (0.660.85)
00.61.4
Synonymous OE?0.77
01.21.6
LoF obs/exp: 10 / 23.5Missense obs/exp: 158 / 210.8Syn Z: 1.52
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveUBA5-related severe infantile-onset encephalopathyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7036th %ile
GOF
0.6248th %ile
LOF
0.2969th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

304 submitted variants in ClinVar

Classification Summary

Pathogenic27
Likely Pathogenic18
VUS116
Likely Benign125
Benign4
Conflicting8
27
Pathogenic
18
Likely Pathogenic
116
VUS
125
Likely Benign
4
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
17
5
5
0
27
Likely Pathogenic
8
8
1
1
18
VUS
2
107
5
2
116
Likely Benign
0
3
57
65
125
Benign
0
1
3
0
4
Conflicting
8
Total271247168298

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

12 pathogenic / likely-pathogenic (of 22) ClinVar copy-number / structural variants overlap UBA5 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

UBA5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →